_id
6915ef88bc934aba376b1f57
Ticker
RLFTY
Name
Relief Therapeutics Holding AG
Exchange
OTCQB
Address
Chemin de Roseneck 5, Lausanne, Switzerland, 1006
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://mindmazetherapeutics.com
Description
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Last Close
1.95
Volume
1399
Current Price
2.4399
Change
-0.91
Last Updated
2026-01-06T10:20:06.700Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
434568896
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
154102442
Income Tax Expense
-3821500
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
12792000
Short Term Investments
-
Receivables
2068000
Inventories
450000
Total Current Assets
16360000
Property Plant Equipment
3219000
Total Assets
125779000
Payables
2173000
Short Term Debt
-
Long Term Debt
13000
Total Liabilities
31413000
Equity
94366000
Bs_currency_symbol
USD
Depreciation
852000
Change In Working Capital
-
Cash From Operations
-5233000
Capital Expenditures
184500
Cash From Investing
-110000
Cash From Financing
2087000
Net Change In Cash
-3222500
Cf_currency_symbol
USD
PE
-
PB
0.3159164245183647
ROE
-
ROA
-
FCF
-5417500
Fcf Percent
-
Piotroski FScore
0
Health Score
59
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
2.5
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
6
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12218439
Quarters > 0 > income Statement > income Tax Expense
-3821500
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
12792000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2068000
Quarters > 0 > balance Sheet > inventories
450000
Quarters > 0 > balance Sheet > total Current Assets
16360000
Quarters > 0 > balance Sheet > property Plant Equipment
3219000
Quarters > 0 > balance Sheet > total Assets
125779000
Quarters > 0 > balance Sheet > payables
2173000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
13000
Quarters > 0 > balance Sheet > total Liabilities
31413000
Quarters > 0 > balance Sheet > equity
94366000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-28249500
Quarters > 0 > cash Flow > depreciation
852000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-5233000
Quarters > 0 > cash Flow > capital Expenditures
184500
Quarters > 0 > cash Flow > cash From Investing
-110000
Quarters > 0 > cash Flow > cash From Financing
2087000
Quarters > 0 > cash Flow > net Change In Cash
-3222500
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0.3159164245183647
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-5417500
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
59
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-3821500
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2068000
Quarters > 1 > balance Sheet > inventories
450000
Quarters > 1 > balance Sheet > total Current Assets
16360000
Quarters > 1 > balance Sheet > property Plant Equipment
3219000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
2173000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7125000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-28249500
Quarters > 1 > cash Flow > depreciation
852000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-5233000
Quarters > 1 > cash Flow > capital Expenditures
184500
Quarters > 1 > cash Flow > cash From Investing
-110000
Quarters > 1 > cash Flow > cash From Financing
2087000
Quarters > 1 > cash Flow > net Change In Cash
-3222500
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-5417500
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4405525186
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
19237000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2255000
Quarters > 2 > balance Sheet > inventories
227000
Quarters > 2 > balance Sheet > total Current Assets
22583000
Quarters > 2 > balance Sheet > property Plant Equipment
2691000
Quarters > 2 > balance Sheet > total Assets
188798000
Quarters > 2 > balance Sheet > payables
1625000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
16000
Quarters > 2 > balance Sheet > total Liabilities
43381000
Quarters > 2 > balance Sheet > equity
145417000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-12145000
Quarters > 2 > cash Flow > depreciation
852000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-5233000
Quarters > 2 > cash Flow > capital Expenditures
184500
Quarters > 2 > cash Flow > cash From Investing
-110000
Quarters > 2 > cash Flow > cash From Financing
2087000
Quarters > 2 > cash Flow > net Change In Cash
-3222500
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
73.91873647043606
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-5417500
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
52
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2255000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
0
Quarters > 3 > cash Flow > depreciation
852000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-5233000
Quarters > 3 > cash Flow > capital Expenditures
184500
Quarters > 3 > cash Flow > cash From Investing
-110000
Quarters > 3 > cash Flow > cash From Financing
2087000
Quarters > 3 > cash Flow > net Change In Cash
-3222500
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-5417500
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8417000
Annuals > 0 > income Statement > cost Of Revenue
2575000
Annuals > 0 > income Statement > gross Profit
5842000
Annuals > 0 > income Statement > operating Expenses
16323000
Annuals > 0 > income Statement > operating Income
-7906000
Annuals > 0 > income Statement > interest Expense
215000
Annuals > 0 > income Statement > pretax Income
-19356000
Annuals > 0 > income Statement > net Income
-17119000
Annuals > 0 > income Statement > eps
-1.3651037256351233
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12540439
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-93.92895330877985
Annuals > 0 > income Statement > total Other Income Expense Net
-11371000
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
15080000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1437000
Annuals > 0 > balance Sheet > inventories
1042000
Annuals > 0 > balance Sheet > total Current Assets
19688000
Annuals > 0 > balance Sheet > property Plant Equipment
2396000
Annuals > 0 > balance Sheet > total Assets
53224000
Annuals > 0 > balance Sheet > payables
1627000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
16560000
Annuals > 0 > balance Sheet > equity
36664000
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
-17119000
Annuals > 0 > cash Flow > depreciation
2561000
Annuals > 0 > cash Flow > change In Working Capital
2679000
Annuals > 0 > cash Flow > cash From Operations
-2916000
Annuals > 0 > cash Flow > capital Expenditures
172000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-862000
Annuals > 0 > cash Flow > net Change In Cash
623000
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
-1.3651037256351233
Annuals > 0 > ratios > PB
0.6532903799367227
Annuals > 0 > ratios > ROE
-46.69157756927776
Annuals > 0 > ratios > ROA
-32.16406132571772
Annuals > 0 > ratios > FCF
-3088000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.3668765593441844
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
6033000
Annuals > 1 > income Statement > cost Of Revenue
1736000
Annuals > 1 > income Statement > gross Profit
4297000
Annuals > 1 > income Statement > operating Expenses
25811000
Annuals > 1 > income Statement > operating Income
-19778000
Annuals > 1 > income Statement > interest Expense
330000
Annuals > 1 > income Statement > pretax Income
-111684000
Annuals > 1 > income Statement > net Income
-98181000
Annuals > 1 > income Statement > eps
-7.8291517545757365
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12540439
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-327.8302668655727
Annuals > 1 > income Statement > total Other Income Expense Net
-91115000
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
14556000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1171000
Annuals > 1 > balance Sheet > inventories
557000
Annuals > 1 > balance Sheet > total Current Assets
18304000
Annuals > 1 > balance Sheet > property Plant Equipment
2967000
Annuals > 1 > balance Sheet > total Assets
76390000
Annuals > 1 > balance Sheet > payables
1025000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
9000
Annuals > 1 > balance Sheet > total Liabilities
24162000
Annuals > 1 > balance Sheet > equity
52228000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-98181000
Annuals > 1 > cash Flow > depreciation
3318000
Annuals > 1 > cash Flow > change In Working Capital
-991000
Annuals > 1 > cash Flow > cash From Operations
-17612000
Annuals > 1 > cash Flow > capital Expenditures
446000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
4050000
Annuals > 1 > cash Flow > net Change In Cash
-4867000
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
-7.8291517545757365
Annuals > 1 > ratios > PB
0.4586091462433943
Annuals > 1 > ratios > ROE
-187.98537183120166
Annuals > 1 > ratios > ROA
-128.5259850765807
Annuals > 1 > ratios > FCF
-18058000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.9932040444223436
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
6081000
Annuals > 2 > income Statement > cost Of Revenue
13643000
Annuals > 2 > income Statement > gross Profit
-7562000
Annuals > 2 > income Statement > operating Expenses
42863000
Annuals > 2 > income Statement > operating Income
-36782000
Annuals > 2 > income Statement > interest Expense
156000
Annuals > 2 > income Statement > pretax Income
-54316000
Annuals > 2 > income Statement > net Income
-50790000
Annuals > 2 > income Statement > eps
-0.01152870494564459
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4405525186
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-50300000
Annuals > 2 > income Statement > operating Margin
-604.8676204571617
Annuals > 2 > income Statement > total Other Income Expense Net
-16940000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
19237000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1321000
Annuals > 2 > balance Sheet > inventories
227000
Annuals > 2 > balance Sheet > total Current Assets
22583000
Annuals > 2 > balance Sheet > property Plant Equipment
2691000
Annuals > 2 > balance Sheet > total Assets
188798000
Annuals > 2 > balance Sheet > payables
1625000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
16000
Annuals > 2 > balance Sheet > total Liabilities
43381000
Annuals > 2 > balance Sheet > equity
145417000
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
-50790000
Annuals > 2 > cash Flow > depreciation
3860000
Annuals > 2 > cash Flow > change In Working Capital
5592000
Annuals > 2 > cash Flow > cash From Operations
-24126000
Annuals > 2 > cash Flow > capital Expenditures
521000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
6417000
Annuals > 2 > cash Flow > net Change In Cash
-25708000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.01152870494564459
Annuals > 2 > ratios > PB
57.864988998947844
Annuals > 2 > ratios > ROE
-34.92714056815915
Annuals > 2 > ratios > ROA
-26.901768027203676
Annuals > 2 > ratios > FCF
-24647000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.053116263772406
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3321000
Annuals > 3 > income Statement > cost Of Revenue
19774000
Annuals > 3 > income Statement > gross Profit
-16453000
Annuals > 3 > income Statement > operating Expenses
38585000
Annuals > 3 > income Statement > operating Income
-35264000
Annuals > 3 > income Statement > interest Expense
194000
Annuals > 3 > income Statement > pretax Income
-35525000
Annuals > 3 > income Statement > net Income
-34705000
Annuals > 3 > income Statement > eps
-0.008436921411160083
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4113467260
Annuals > 3 > income Statement > income Tax Expense
-820000
Annuals > 3 > income Statement > EBITDA
-33295000
Annuals > 3 > income Statement > operating Margin
-1061.8488407106292
Annuals > 3 > income Statement > total Other Income Expense Net
362000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
44761000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
1302000
Annuals > 3 > balance Sheet > inventories
391000
Annuals > 3 > balance Sheet > total Current Assets
54970000
Annuals > 3 > balance Sheet > property Plant Equipment
2536000
Annuals > 3 > balance Sheet > total Assets
251618000
Annuals > 3 > balance Sheet > payables
1700000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
396000
Annuals > 3 > balance Sheet > total Liabilities
70088000
Annuals > 3 > balance Sheet > equity
181530000
Annuals > 3 > balance Sheet > currency_symbol
CHF
Annuals > 3 > cash Flow > net Income
-34705000
Annuals > 3 > cash Flow > depreciation
2036000
Annuals > 3 > cash Flow > change In Working Capital
-5234000
Annuals > 3 > cash Flow > cash From Operations
-35718000
Annuals > 3 > cash Flow > capital Expenditures
13708000
Annuals > 3 > cash Flow > cash From Investing
-30262000
Annuals > 3 > cash Flow > cash From Financing
67689000
Annuals > 3 > cash Flow > net Change In Cash
1607000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.008436921411160083
Annuals > 3 > ratios > PB
43.28057327494078
Annuals > 3 > ratios > ROE
-19.11805211259847
Annuals > 3 > ratios > ROA
-13.79273342924592
Annuals > 3 > ratios > FCF
-49426000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-14.882866606443843
Annuals > 3 > health Score
27
Valuation > metrics > PB
0.3159164245183647
Valuation > final Score
70
Valuation > verdict
68.4% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3328847254307696
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
7.528762080073631
Liquidity > metrics > Quick Ratio
7.321675103543488
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
80
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-20T22:29:34.666Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-08
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AArthur J. Gallagher Launches Massive $8.5B Stock Offering for AssuredPartners Deal - Stock Titan
12/9/2024
Arthur J. Gallagher Launches Massive $8.5B Stock Offering for AssuredPartners Deal Stock Titan
Read more →aTyr Pharma: Two 2025 Data Readouts Could Provide Inflection Point Seeking Alpha
Read more →Showing 2 of 3
(Last Updated 2023-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Relief Therapeutics Holding AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.